HB 2444 Arizona House · 57th Legislature - Second Regular Session

pharmacists; independent testing; treatment

HB 2444 allows Arizona pharmacists to independently order, perform, and interpret certain FDA-waived tests (like flu, strep, or COVID-19 tests) and initiate treatment for specific conditions - including influenza, strep throat, HIV prevention, and other public health threats - without a physician's direct order. It directly affects pharmacists (who gain new clinical authority) and patients aged six or older who need treatment for those conditions. Key provisions require pharmacists to follow a statewide protocol covering documentation, referrals, patient screening, and evidence-based guidelines, while mandating notification to a patient’s primary care provider within 72 hours of treatment. The bill also prohibits pharmacists from prescribing opioids or treating minors without parental consent.
Bill status passed 3 of 5 stages cleared
Introduction
Jan 2026
Committee Review
House Passage
Mar 2026
Senate Passage
Governor
Introduced Jan 20, 2026 Last action Mar 17, 2026
Maddy AI version diff · 1 comparison

What changed between versions

Introduced Version House Engrossed Version (03/10/2026) · 8 edits · Mar 16, 2026
MODERATE
The bill was expanded to include three new sections instead of one, significantly broadening the pharmacist's authority. The age limit for independent testing and treatment was raised from six to twelve years old. A new section was added to allow pharmacists to provide HIV pre- and post-exposure prophylaxis, while another section was added to establish an advisory committee that must review protocols annually instead of having a fixed repeal date.
Scope change
The bill's scope expanded from a single section on general independent testing to three sections covering general protocols, a new HIV-specific protocol, and the establishment of an ongoing advisory committee.
ELIGIBILITY

The minimum age for a pharmacist to independently order tests and initiate treatment was increased from six years old to twelve years old.

SCOPE

A new section was added granting pharmacists the authority to provide HIV pre-exposure and post-exposure prophylaxis under specific testing and counseling conditions.

REQUIREMENT

The requirement for pharmacists to maintain records was clarified to include specific details like history of illness, examination findings, vitals, and a plan of care.

A new requirement mandates that pharmacists performing these services must maintain professional liability insurance.

The list of conditions pharmacists can treat was expanded to include any condition related to an emerging public health threat identified by the state health department.

A new requirement mandates that pharmacies display a notice and include specific language in consent paperwork explaining that services are performed without physician oversight.

ENFORCEMENT

A new provision explicitly states that an employer cannot overrule a pharmacist's decision to decline providing these authorized services.

TIMELINE

The timeline for the advisory committee was changed from a fixed repeal date in 2027 to an annual review cycle that continues indefinitely.

Floor votes · House Mar 10, 2026

How they voted

3322
Passed · 5 other
Total votes 60
Mar 10, 2026
D Democratic27
19 Yea 4 Nay 4
70% Yea
R Republican33
14 Yea 18 Nay 1
54% Nay
Vote distribution
All Yea All Nay Mixed No data
Full legislative history

Actions timeline

Total actions
9
Key actions
6
Committee
0
Amendments
3
Mar 17, 2026
Lower · Passed
DPA
lower
Mar 17, 2026
Lower · Passed
PASSED
lower
Mar 16, 2026
Lower · Passed
PASSED
lower
Mar 10, 2026
Lower · Passed
PASSED
lower
Mar 4, 2026
Lower · Passed
DPA
lower
Feb 16, 2026
Lower · Passed
DPA
lower
1 primary · 1 co-sponsor

Sponsors